Your session is about to expire
← Back to Search
Hemodialysis Access Techniques for Chronic Kidney Disease in the Elderly (ELDERLY Trial)
N/A
Recruiting
Led By Eric K Peden, MD
Research Sponsored by E. Peden, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Expected to undergo hemodialysis within 6 months of presentation
Aged ≥70 years of all ethnicities
Must not have
Intraoperative decision was made in favor of fistula instead of graft
Unable or refuse to abide with follow-up
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare autologous arteriovenous fistulas (AVF) to hemodialysis access grafts in the elderly, enrolling 270 patients over 5 years.
Who is the study for?
This trial is for people aged 70 or older with advanced kidney disease who need hemodialysis and can have surgery to create a dialysis access. They must be currently on hemodialysis due to previous access failure, and not have bleeding disorders, active infections, certain vein issues unless recently imaged, or an inability to follow the study plan.
What is being tested?
The study compares two surgical methods for creating dialysis access in elderly patients: making a fistula from their own blood vessels or implanting a synthetic graft. It's randomized-controlled, meaning participants are randomly assigned to one of these two groups without knowing which one.
What are the potential side effects?
Possible side effects include complications at the surgery site like infection or clotting, problems with blood flow through the created access point leading to additional interventions, and general risks associated with anesthesia and surgical procedures.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am expected to start hemodialysis within the next 6 months.
Select...
I am 70 years old or older.
Select...
My blood vessels are suitable for creating a connection for dialysis.
Select...
I am on hemodialysis due to previous access failure.
Select...
I have severe kidney disease and need dialysis.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My surgery involved creating a fistula instead of using a graft.
Select...
I cannot or will not follow the study's follow-up requirements.
Select...
I have a condition that affects how my blood clots.
Select...
I do not have any active infections.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Analyze hemodialysis (HD) access creation, arteriovenous (AV) fistula vs Graft, in elderly patients.
Functional cumulative patency rate at 12 months
Secondary study objectives
To compare and analyze the estimated costs with both types of hemodialysis interventions and their postoperative outcomes.
Using Disease Outcomes Quality Initiative quality of life tool to evaluate and compare the overall improvement in outcome with respect to morbidity in the 2 years post fistula/graft procedure
Using Disease Outcomes Quality Initiative quality of life tool to evaluate and compare the overall improvement in outcome with respect to mortality in the 2 years post fistula/graft procedure
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Surgical graft implantActive Control2 Interventions
Patients randomized to surgical graft, will have a commercially available graft surgically implanted to be used for hemodialysis access.
Group II: Surgical fistula creation from patient's anatomyActive Control1 Intervention
Patients randomized to surgical arteriovenous fistula will have a fistula surgically created from their anatomy to be used for hemodialysis access.
Find a Location
Who is running the clinical trial?
E. Peden, MDLead Sponsor
1 Previous Clinical Trials
20 Total Patients Enrolled
The Methodist Hospital Research InstituteOTHER
287 Previous Clinical Trials
81,510 Total Patients Enrolled
Eric K Peden, MDPrincipal InvestigatorThe Methodist Hospital Research Institute
Eric Peden, MDPrincipal InvestigatorThe Methodist Hospital Research Institute
2 Previous Clinical Trials
300 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am expected to start hemodialysis within the next 6 months.My surgery involved creating a fistula instead of using a graft.You have a narrow central vein, but you can still participate if you have a catheter or pacemaker and had a vein check within the last 6 months.I am 70 years old or older.My blood vessels are suitable for creating a connection for dialysis.I cannot or will not follow the study's follow-up requirements.I have a condition that affects how my blood clots.I do not have any active infections.I am on hemodialysis due to previous access failure.I have severe kidney disease and need dialysis.
Research Study Groups:
This trial has the following groups:- Group 1: Surgical graft implant
- Group 2: Surgical fistula creation from patient's anatomy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.